Preclinical testing refers to the initial phase of research aimed at gathering data on the safety and efficacy of a nanotechnology-based product before it can be tested in humans. This stage involves in vitro (test tube or cell culture) and in vivo (animal) experiments to assess the biological interactions, pharmacokinetics, and potential toxicological effects of the nanomaterial.